p53 tumour suppressor gene expression in pancreatic neuroendocrine tumour cells.
Open Access
- 1 March 1996
- Vol. 38 (3) , 403-409
- https://doi.org/10.1136/gut.38.3.403
Abstract
Neuroendocrine pancreatic tumours grow slower and metastasise later than ductal and acinar carcinomas. The expression of the p53 tumour suppressor gene in pancreatic neuroendocrine tumour cells is unknown. Pancreatic neuroendocrine cell lines (n = 5) and human tumour tissues (n = 19) were studied for changed p53 coding sequence, transcription, and translation. Proliferative activity of tumour cells was determined analysing Ki-67 expression. No mutation in the p53 nucleotide sequence of neuroendocrine tumour cell was found. However, an overexpression of p53 could be detected in neuroendocrine pancreatic tumour cell lines at a protein level. As no p53 mutations were seen, it is suggested that post-translational events can also lead to an overexpression of p53.Keywords
This publication has 45 references indexed in Scilit:
- A Study of Biological Behavior Based on the Expression of a Proliferating Antigen in Neuroendocrine Tumors of the Digestive SystemTumor Biology, 1992
- Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activationCell, 1991
- p53 Mutations in Human CancersScience, 1991
- Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformationPublished by Elsevier ,1991
- Mutational hot spot in the p53 gene in human hepatocellular carcinomasNature, 1991
- Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern AfricaNature, 1991
- Increased expression of mutant forms of p53 oncogene in primary lung cancerThe Lancet, 1990
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- Multipotential phenotypic expression of genes encoding peptide hormones in rat insulinoma cell lines.Journal of Clinical Investigation, 1987
- Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell lineNature, 1979